172 related articles for article (PubMed ID: 25860932)
41. Controlling tumor invasion: bevacizumab and BMP4 for glioblastoma.
Rahman M; Azari H; Deleyrolle L; Millette S; Zeng H; Reynolds BA
Future Oncol; 2013 Sep; 9(9):1389-96. PubMed ID: 23980685
[TBL] [Abstract][Full Text] [Related]
42. Treating brain tumor-initiating cells using a combination of myxoma virus and rapamycin.
Zemp FJ; Lun X; McKenzie BA; Zhou H; Maxwell L; Sun B; Kelly JJ; Stechishin O; Luchman A; Weiss S; Cairncross JG; Hamilton MG; Rabinovich BA; Rahman MM; Mohamed MR; Smallwood S; Senger DL; Bell J; McFadden G; Forsyth PA
Neuro Oncol; 2013 Jul; 15(7):904-20. PubMed ID: 23585629
[TBL] [Abstract][Full Text] [Related]
43. Expression of bone morphogenetic protein 7 in lung cancer and its biological impact on lung cancer cells.
Chen J; Ye L; Xie F; Yang Y; Zhang L; Jiang WG
Anticancer Res; 2010 Apr; 30(4):1113-20. PubMed ID: 20530416
[TBL] [Abstract][Full Text] [Related]
44. Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.
Liu C; Sarkaria JN; Petell CA; Paraskevakou G; Zollman PJ; Schroeder M; Carlson B; Decker PA; Wu W; James CD; Russell SJ; Galanis E
Clin Cancer Res; 2007 Dec; 13(23):7155-65. PubMed ID: 18056196
[TBL] [Abstract][Full Text] [Related]
45. Estrogen-related receptor β activation and isoform shifting by cdc2-like kinase inhibition restricts migration and intracranial tumor growth in glioblastoma.
Tiek DM; Khatib SA; Trepicchio CJ; Heckler MM; Divekar SD; Sarkaria JN; Glasgow E; Riggins RB
FASEB J; 2019 Dec; 33(12):13476-13491. PubMed ID: 31570001
[TBL] [Abstract][Full Text] [Related]
46. Propentofylline inhibits glioblastoma cell invasion and survival by targeting the TROY signaling pathway.
Dhruv HD; Roos A; Tomboc PJ; Tuncali S; Chavez A; Mathews I; Berens ME; Loftus JC; Tran NL
J Neurooncol; 2016 Feb; 126(3):397-404. PubMed ID: 26559543
[TBL] [Abstract][Full Text] [Related]
47. Knockdown of ribosomal protein S15A induces human glioblastoma cell apoptosis.
Zhang C; Fu J; Xue F; Ryu B; Zhang T; Zhang S; Sun J; Xu X; Shen Z; Zheng L; Chen X
World J Surg Oncol; 2016 Apr; 14():129. PubMed ID: 27130037
[TBL] [Abstract][Full Text] [Related]
48. NCoR controls glioblastoma tumor cell characteristics.
Heldring N; Nyman U; Lönnerberg P; Onnestam S; Herland A; Holmberg J; Hermanson O
Neuro Oncol; 2014 Jan; 16(2):241-9. PubMed ID: 24335696
[TBL] [Abstract][Full Text] [Related]
49. MRP3: a molecular target for human glioblastoma multiforme immunotherapy.
Kuan CT; Wakiya K; Herndon JE; Lipp ES; Pegram CN; Riggins GJ; Rasheed A; Szafranski SE; McLendon RE; Wikstrand CJ; Bigner DD
BMC Cancer; 2010 Sep; 10():468. PubMed ID: 20809959
[TBL] [Abstract][Full Text] [Related]
50. Enhanced expression of Vastatin inhibits angiogenesis and prolongs survival in murine orthotopic glioblastoma model.
Li Y; Li J; Woo YM; Shen Z; Yao H; Cai Y; Lin MC; Poon WS
BMC Cancer; 2017 Feb; 17(1):126. PubMed ID: 28193190
[TBL] [Abstract][Full Text] [Related]
51. Let-7 microRNA inhibits the proliferation of human glioblastoma cells.
Lee ST; Chu K; Oh HJ; Im WS; Lim JY; Kim SK; Park CK; Jung KH; Lee SK; Kim M; Roh JK
J Neurooncol; 2011 Mar; 102(1):19-24. PubMed ID: 20607356
[TBL] [Abstract][Full Text] [Related]
52. Tyrosine kinase Eph receptor A6 sensitizes glioma-initiating cells towards bone morphogenetic protein-induced apoptosis.
Raja E; Morikawa M; Nishida J; Tanabe R; Takahashi K; Seeherman HJ; Saito N; Todo T; Miyazono K
Cancer Sci; 2019 Nov; 110(11):3486-3496. PubMed ID: 31483918
[TBL] [Abstract][Full Text] [Related]
53. EVA1A inhibits GBM cell proliferation by inducing autophagy and apoptosis.
Shen X; Kan S; Liu Z; Lu G; Zhang X; Chen Y; Bai Y
Exp Cell Res; 2017 Mar; 352(1):130-138. PubMed ID: 28185834
[TBL] [Abstract][Full Text] [Related]
54. Dexamethasone-Mediated Activation of Fibronectin Matrix Assembly Reduces Dispersal of Primary Human Glioblastoma Cells.
Shannon S; Vaca C; Jia D; Entersz I; Schaer A; Carcione J; Weaver M; Avidar Y; Pettit R; Nair M; Khan A; Foty RA
PLoS One; 2015; 10(8):e0135951. PubMed ID: 26284619
[TBL] [Abstract][Full Text] [Related]
55. The Wnt inhibitory factor 1 (WIF1) is targeted in glioblastoma and has a tumor suppressing function potentially by induction of senescence.
Lambiv WL; Vassallo I; Delorenzi M; Shay T; Diserens AC; Misra A; Feuerstein B; Murat A; Migliavacca E; Hamou MF; Sciuscio D; Burger R; Domany E; Stupp R; Hegi ME
Neuro Oncol; 2011 Jul; 13(7):736-47. PubMed ID: 21642372
[TBL] [Abstract][Full Text] [Related]
56. Identification of two glioblastoma-associated stromal cell subtypes with different carcinogenic properties in histologically normal surgical margins.
Clavreul A; Etcheverry A; Tétaud C; Rousseau A; Avril T; Henry C; Mosser J; Menei P
J Neurooncol; 2015 Mar; 122(1):1-10. PubMed ID: 25503303
[TBL] [Abstract][Full Text] [Related]
57. Anti-YKL-40 antibody and ionizing irradiation synergistically inhibit tumor vascularization and malignancy in glioblastoma.
Shao R; Francescone R; Ngernyuang N; Bentley B; Taylor SL; Moral L; Yan W
Carcinogenesis; 2014 Feb; 35(2):373-82. PubMed ID: 24282289
[TBL] [Abstract][Full Text] [Related]
58. The sustained and targeted treatment of hemangiomas by propranolol-loaded CD133 aptamers conjugated liposomes-in-microspheres.
Guo X; Dong C; Liu Q; Zhu X; Zuo S; Zhang H
Biomed Pharmacother; 2019 Jun; 114():108823. PubMed ID: 30965238
[TBL] [Abstract][Full Text] [Related]
59. [BMP7 signaling via BMPR1A, BMPR1B inhibits the proliferation of lung large carcinoma NCI-H460 cell].
Xu H; Qi Y; Dun S; Gao Y; Qiu X
Zhongguo Fei Ai Za Zhi; 2010 Jul; 13(7):659-64. PubMed ID: 20673479
[TBL] [Abstract][Full Text] [Related]
60. Biological effects of BMP7 on small-cell lung cancer cells and its bone metastasis.
Shen W; Pang H; Xin B; Duan L; Liu L; Zhang H
Int J Oncol; 2018 Sep; 53(3):1354-1362. PubMed ID: 30015928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
